SLAB — Silicon Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $3.68bn
- $3.28bn
- $782.26m
- 65
- 34
- 68
- 56
Annual cashflow statement for Silicon Laboratories, fiscal year end - December 30th, USD millions except per share, conversion factor applied.
C2019 December 28th | C2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 19.3 | 12.5 | 91.4 | 2,117 | -34.5 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 79.9 | 89.4 | -10.4 | -2,298 | 65.2 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8.62 | -18.5 | -47.6 | 20.7 | -100 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 167 | 136 | 71.8 | -100 | -30.3 |
| Capital Expenditures | -15.3 | -18.1 | -26.5 | -28.6 | -22.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -91.5 | -343 | 267 | 2,300 | 492 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -107 | -361 | 241 | 2,271 | 470 |
| Financing Cash Flow Items | -16.3 | -18.1 | -15.4 | -22.2 | -18.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -29.6 | 201 | -887 | -1,299 | -712 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 30.1 | -24.4 | -575 | 872 | -272 |